ISTA Pharmaceuticals has set its sights on treating eye diseases. The Bausch & Lomb pharmaceutical subsidiary has products in development and on the market. ISTA's marketed products include Bepreve (for itchy eyes associated with allergic conjunctivitis), Istalol (a glaucoma treatment), and Bromday (used for pain and inflammation following cataract surgery) in the US. Its drug Vitrase is a spreading agent that promotes absorption of injected drugs. The drug candidates in the company's pipeline include treatments for dry eye syndrome, ocular pain, and inflammation. ISTA has additional ocular and allergy treatments in research and development stages.